Volume 120, Issue 1 , Pages 105-112, July 2007
Identification and characterization of a novel allergen from Blomia tropicalis: Blo t 21
Background
Allergenic components from Blomia tropicalis are important triggers of allergies in the tropics.
Objective
We sought to identify and characterize a novel allergen, Blo t 21, from B tropicalis.
Methods
Blo t 21 was initially identified from an expressed sequence tag database generated from a B tropicalis cDNA library. Allergenicity of this antigen was examined by means of skin prick testing, ELISA, and IgE immuno-dot blotting. We evaluated whether Blo t 21 and Blo t 5 were cross-reactive by using IgE inhibition ELISAs.
Results
Blo t 21, a 129-amino-acid protein sharing 39% identity with Blo t 5, is a product of a single-copy gene. It has an α-helical secondary structure and localizes to midgut and hindgut contents of B tropicalis, as well as fecal particles. Positive responses to Blo t 21 were shown in 93% (40/43) by means of ELISA and 95% (41/43) by means of skin prick testing when assayed in 43 adult patients with ongoing persistent allergic rhinitis. However, sera of 494 consecutive individuals attending outpatient allergy clinics over 1½ years showed 57.9% (286/494) had positive responses to Blo t 21. Although the majority (>75%) of sensitized individuals were cosensitized to both Blo t 5 and Blo t 21, these 2 allergens had a low-to-moderate degree of cross-reactivity.
Conclusion
Blo t 21 is a major allergen in B tropicalis that is not highly cross-reactive to Blo t 5, despite sharing some sequence and structural identity.
Clinical implications
Blo t 21, representing a new group of allergens, is an important B tropicalis allergen.
Key words: Dust mite, Blomia tropicalis, allergen, IgE binding, cross-reactivity, immunolocalization, genomic organization
Abbreviations used: CD, Circular dichroism, EST, Expressed sequence tagging, ORF, Open reading frame, SPT, Skin prick test
Supported by the Biomedical Research Council of the Agency for Science, Technology and Research in Singapore.Disclosure of potential conflict of interest: F. T. Chew and D. Y. Wang have received grant support from the Singapore Biomedical Research Council, the Singapore National Medical Research Center, and the National University of Singapore Academic Research Fund. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(07)00435-6
doi:10.1016/j.jaci.2007.02.032
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 120, Issue 1 , Pages 105-112, July 2007
